| Primary |
| Transient Ischaemic Attack |
18.9% |
| Cerebrovascular Accident Prophylaxis |
13.3% |
| Prophylaxis |
10.0% |
| Essential Thrombocythaemia |
8.9% |
| Cerebrovascular Accident |
7.8% |
| Hypertension |
7.8% |
| Depression |
5.6% |
| Hypercholesterolaemia |
4.4% |
| Adverse Event |
3.3% |
| Cerebral Infarction |
3.3% |
| Blood Pressure |
2.2% |
| Immunisation |
2.2% |
| Osteoporotic Fracture |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Antiplatelet Therapy |
1.1% |
| Atrial Fibrillation |
1.1% |
| Benign Prostatic Hyperplasia |
1.1% |
| Cardiovascular Disorder |
1.1% |
| Cardiovascular Event Prophylaxis |
1.1% |
|
| Vomiting |
13.0% |
| Gastrointestinal Haemorrhage |
10.9% |
| Cerebrovascular Accident |
6.5% |
| Haemorrhage |
6.5% |
| Headache |
6.5% |
| Myocardial Infarction |
6.5% |
| Thrombocytopenia |
6.5% |
| Condition Aggravated |
4.3% |
| Myalgia |
4.3% |
| Nightmare |
4.3% |
| Pericardial Effusion |
4.3% |
| Rash |
4.3% |
| Suicide Attempt |
4.3% |
| Transient Ischaemic Attack |
4.3% |
| Acute Coronary Syndrome |
2.2% |
| Blood Glucose Increased |
2.2% |
| Blood Pressure Decreased |
2.2% |
| Blood Urine Present |
2.2% |
| Death |
2.2% |
| Deep Vein Thrombosis |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.1% |
| Essential Thrombocythaemia |
18.7% |
| Hypertension |
8.2% |
| Product Used For Unknown Indication |
8.2% |
| Drug Exposure During Pregnancy |
7.0% |
| Depression |
4.7% |
| Prophylaxis |
4.1% |
| Anaemia |
3.5% |
| Thrombosis Prophylaxis |
3.5% |
| Acute Myeloid Leukaemia |
1.8% |
| Blood Cholesterol |
1.8% |
| Breast Cancer |
1.8% |
| Foetal Exposure During Pregnancy |
1.8% |
| Osteoporosis |
1.8% |
| Transient Ischaemic Attack |
1.8% |
| Pain |
1.2% |
| Arthritis |
0.6% |
| Atrial Flutter |
0.6% |
| Blood Homocysteine Increased |
0.6% |
| Cerebrovascular Accident |
0.6% |
|
| Myalgia |
16.2% |
| General Physical Health Deterioration |
10.8% |
| Pericardial Effusion |
10.8% |
| Pre-eclampsia |
8.1% |
| Weight Decreased |
8.1% |
| Pneumonia |
5.4% |
| Thrombocytopenia |
5.4% |
| Angioedema |
2.7% |
| Duodenal Ulcer |
2.7% |
| Foetal Growth Restriction |
2.7% |
| Gastric Haemorrhage |
2.7% |
| International Normalised Ratio Decreased |
2.7% |
| Iron Deficiency Anaemia |
2.7% |
| Metabolic Acidosis |
2.7% |
| Nightmare |
2.7% |
| Normal Newborn |
2.7% |
| Overdose |
2.7% |
| Potentiating Drug Interaction |
2.7% |
| Premature Baby |
2.7% |
| Respiratory Arrest |
2.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
32.1% |
| Product Used For Unknown Indication |
15.7% |
| Hypertension |
12.3% |
| Rheumatoid Arthritis |
4.8% |
| Prophylaxis |
3.8% |
| Pain |
3.6% |
| Depression |
3.4% |
| Parkinson's Disease |
3.4% |
| Cerebrovascular Accident |
3.0% |
| Type 2 Diabetes Mellitus |
2.4% |
| Hypercholesterolaemia |
2.2% |
| Anticoagulant Therapy |
2.0% |
| Transient Ischaemic Attack |
2.0% |
| Diabetes Mellitus |
1.6% |
| Macular Degeneration |
1.6% |
| Cerebrovascular Accident Prophylaxis |
1.4% |
| Hepatic Neoplasm Malignant |
1.4% |
| Blood Cholesterol Increased |
1.2% |
| Disturbance In Attention |
1.2% |
| Insomnia |
1.2% |
|
| Vomiting |
11.7% |
| Cerebrovascular Accident |
9.1% |
| Tendon Rupture |
9.1% |
| Leukocytosis |
7.8% |
| Cerebral Infarction |
5.2% |
| Dysarthria |
5.2% |
| Hypotension |
5.2% |
| Injury |
5.2% |
| Pain In Extremity |
5.2% |
| Thrombocytopenia |
5.2% |
| Urine Analysis Abnormal |
5.2% |
| Aplastic Anaemia |
3.9% |
| Rash |
3.9% |
| Blood Glucose Increased |
2.6% |
| Cerebral Thrombosis |
2.6% |
| Dyspnoea |
2.6% |
| Flushing |
2.6% |
| Hyperkalaemia |
2.6% |
| Legionella Infection |
2.6% |
| Liver Function Test Abnormal |
2.6% |
|
| Interacting |
| Cerebrovascular Accident |
50.0% |
| Drug Use For Unknown Indication |
25.0% |
| Immunisation |
16.7% |
| Antiplatelet Therapy |
8.3% |
|
| Pulmonary Fibrosis |
100.0% |
|
